Blueprint library/PD

Pharmaceutical & Bioprocess Development Software

Turn experimental runs into a process definition that can mature, scale, characterize, and transfer.

Product and process targets, unit operations, materials, experiments, parameters, scale models, yields, samples, quality attributes, knowledge claims, process candidates, maturity gates, and transfer readiness connected across ELN, LIMS, equipment, characterization, and tech transfer.

Pharmaceutical & Bioprocess Development Software

The tech transfer that took eighteen months

The process worked at bench scale. It worked at pilot. The development team documented everything. Thousands of pages of reports, protocols, data. Then came tech transfer.

Manufacturing couldn't run from development's documents. The batch record had to be written from scratch. Parameters that were obvious to the development team were buried in slide decks. When questions arose, the scientists who knew the answers had moved on. The "knowledge transfer" was really knowledge excavation. Eighteen months from "process locked" to "first GMP batch."

This isn't a failure of documentation. It's a failure of architecture. Development and manufacturing are running on different systems with different data models. The translation layer is humans reading documents and typing into new systems. That's where knowledge dies.

Tech transfer / translation vs promotion
Legacy tech transfer is a translation project — manual re-authoring. Seal's tech transfer is a configuration change on the same record.
Traditional / 18 months
Development
Word docs, Excel sheets,
SharePoint folders
Translate
Manual transfer
Re-type every parameter
into new MES / QMS
Validate
GMP manufacturing
Validated from scratch
in a new system
Knowledge lost in translation / batch records written from scratch / rationale discarded / 18-month cycle
Seal / days
Development
Structured data in Seal
from day one
Promote
Same record / new state
Parameters locked,
validation linked
Execute
GMP manufacturing
Same record, tighter
enforcement layer
Same data model / rationale preserved / revalidation scoped to the change — the process you develop IS the process you promote
Fig. 1 / Tech Transfer Problem
01

Development in an execution system

Most development teams work in documentation systems. They write protocols, execute experiments, generate reports. The work is real. The data is real. But the output is documents. PDFs, Word files, PowerPoints. That have to be translated into manufacturing systems later.

Seal is an execution system, not a documentation system. When a development scientist defines a unit operation, they're creating a reusable, version-controlled asset. Not writing a document. When they capture a process parameter, it's structured data with context. Not a number in a spreadsheet. When they run an experiment, the execution is recorded with the same rigor that GMP will require.

This isn't about forcing GMP compliance onto development. Development needs flexibility. Scientists need to iterate, explore, adjust. Seal provides that flexibility. But the flexibility happens within a structured framework, not outside of it.

02

Flexible when you need it, rigorous when you don't

Development workflows are different from manufacturing workflows. Scientists need to deviate, try alternatives, document observations that weren't planned. Forcing them into rigid GMP-style execution kills productivity and misses insights.

Seal handles this by separating structure from enforcement. The structure is always there. Unit operations, parameters, materials, equipment. But enforcement is configurable. During early development, parameters are captured but not enforced. Deviations don't require approvals. The scientist has freedom to explore.

As the process matures, controls tighten. Parameter ranges narrow. Deviations require documentation. By late-stage development, the process runs with near-GMP rigor. Not because someone mandated it, but because the process is ready for it.

03

Promote, don't re-author

The tech transfer problem isn't a "documentation problem" to solve with better templates. It's an architecture problem. If development and manufacturing are different systems, translation is unavoidable.

Promote Not Re-author
Fig. 2 / Promote Not Re-author

Seal eliminates translation by keeping development and manufacturing on the same platform. The process you develop is the process you promote. The unit operations, parameters, equipment requirements, material specifications. All of it carries forward. You're not re-authoring a batch record from development documents. You're configuring the validated version of the process you already built.

What changes during promotion? Enforcement tightens. Approvals are required. Deviations route to quality systems. But the process definition. The actual work. Doesn't change. That's what "digital tech transfer" means. Not sending files. Promoting assets.

04

FDA is looking further back

Regulatory expectations have shifted. FDA doesn't just want to see your GMP manufacturing records. They want to understand your process. Why you chose those parameters, how you know they're critical, what happens when they drift. That understanding lives in development.

If development data lives in a documentation system, answering these questions means archaeology. Finding the right reports. Hoping the scientist documented their reasoning. Reconstructing context from fragments.

If development data lives in an execution system. The same one you're running GMP on. The questions answer themselves. Click a CPP and see its history: the experiments that established it, the characterization that confirmed it, the range that emerged from the data. The regulatory story isn't assembled. It's inherent in the data structure.

05

Upstream, downstream, analytical

Process development isn't monolithic. Upstream teams optimize cell culture and fermentation. Downstream teams develop purification. Analytical teams create the methods that measure it all. These aren't separate processes. They're connected parts of one process. But most tools treat them as silos.

Seal models the process as it actually exists. Upstream unit operations connect to downstream unit operations. The output of fermentation is the input to purification. Analytical methods tie to both. When upstream changes affect downstream, the system shows the impact. Because it's one connected model, not three separate documentation projects.

06

Scale-up without surprises

The process that works at 2L doesn't automatically work at 2000L. Scale-up is where development processes break. And where tribal knowledge matters most. "We always do X at large scale" isn't written anywhere. Until it's missed, and the batch fails.

Scale-up Modeling
Fig. 3 / Scale-up Modeling

Seal captures scale models as structured relationships. Parameters at bench scale link to predictions at pilot and commercial. When a scientist establishes a mixing time at bench, the system can project what that means at manufacturing scale. Not through magic, but through the scale correlations your team has built.

This doesn't replace engineering judgment. It augments it with data. The engineer can see not just "what's the mixing time?" but "what was the mixing time at every scale this process has run, and what happened to product quality at each?"

07

Process characterization built in

Understanding your process isn't a separate activity from developing it. Every experiment generates data about parameter impacts. Every run reveals relationships between inputs and outputs. Process characterization is the systematic capture and analysis of these relationships.

Seal treats characterization as a first-class capability. Parameters link to quality attributes. Experiments are designed to explore the design space. The data that establishes your critical process parameters and proven acceptable ranges is the same data you captured during development. Structured, linked, and queryable.

When you need to define your design space for regulatory submissions, you're not reconstructing it from reports. You're querying it from the data. The characterization is already done. It just needs to be presented.

08

The lifecycle advantage

Most organizations treat development, tech transfer, manufacturing, and commercial support as phases with handoffs. Each handoff loses information. Each system transition requires translation. By the time a product is commercial, understanding the original development decisions requires archaeology.

Seal eliminates the phases by eliminating the system boundaries. Development happens on Seal. Tech transfer is promotion within Seal. Manufacturing executes on Seal. Commercial lifecycle management. Process changes, deviations, continuous improvement. Happens on Seal. The data is continuous. The context is preserved. The knowledge compounds instead of eroding.

This isn't just convenience. It's a competitive advantage. Companies that maintain process knowledge can respond faster to problems, improve processes more effectively, and defend their products to regulators with confidence. The platform that holds development also holds manufacturing. The platform that knows why also knows how.

Intended product, dosage form or modality, quality attributes, yield, throughput, scale, facility, containment, raw-material constraints, shelf-life needs, cost, cycle time, control needs, phase, and regulatory strategy establish what the process must achieve.

Candidate processes are compared against that target, so an attractive local result does not obscure a failure against the overall product need.

10

Every run preserves actual execution

Process-candidate version, planned unit operations, materials and lots, prepared solutions, equipment, methods, set points, actual signals, additions, interventions, observations, samples, results, pools, yields, holds, exceptions, raw data, and conclusion form the run.

Exploratory flexibility remains visible as actual execution rather than being edited into a cleaner retrospective protocol.

11

Material variability belongs in process knowledge

Source, grade, specification, lot attributes, preparation, age, storage, hold, substitution, and usage remain connected to run performance and quality outcomes.

Teams can distinguish parameter effects from raw-material or consumable effects, and translate sensitive attributes into supplier, receipt, testing, and process controls.

12

Samples connect the process state to the assay

Each sample retains the source run, unit operation, pool or vessel, time, event, location, matrix, preparation, chain of custody, tests, methods, results, reserve, and disposition.

Analytical results therefore describe a known process state—not a result pasted into a summary table without lineage.

13

Knowledge claims are evidence-backed assets

A conclusion can state that a parameter affects an attribute, a scale model is representative, a hold is acceptable, a material attribute is influential, or a failure mode is controlled. It retains supporting and contradicting runs, analyses, assumptions, uncertainty, scope, reviewer, and use in decisions.

When new evidence arrives, the claim can be challenged or superseded without erasing the historical basis.

14

Maturity gates govern what happens next

Candidate selection, scale-up, characterization readiness, process lock, transfer readiness, validation readiness, and retirement each evaluate defined evidence and open risk.

Ready, ready with conditions, or not ready decisions preserve criteria, evidence, unresolved gaps, conditions, owners, due dates, and approval.

15

The neighboring blueprints have clear jobs

Upstream and downstream development model their specialized operations and material lineages. Process characterization quantifies parameter and attribute relationships and supports a control strategy. Analytical development creates the methods and analytical knowledge. Tech transfer governs sending and receiving-unit readiness. MSAT supports the transferred process in manufacturing.

Process Development is the cross-stage operating model that selects and matures the process candidate across those disciplines.

16

Seal is strongest at promotion

The selected process reaches characterization and transfer with reusable unit operations, materials, parameters, samples, methods, equipment needs, scale assumptions, failure modes, decisions, and evidence links intact.

Manufacturing still authors and approves a controlled recipe appropriate to its facility and validation state, but it starts from governed process knowledge rather than a bundle of documents that must be interpreted from scratch.

Operating model

Native control model
States and decisions owned by this blueprint
03 native controls
Version-Controlled Processes
Processes as reusable assets, not disposable documents. Version history shows how the process evolved. Promote to GMP without re-authoring.
Flexible Development Workflows
Structured framework with configurable enforcement. Capture data consistently while scientists retain freedom to explore and iterate.
Scale Modeling
Link bench-scale parameters to pilot and commercial predictions. See what worked at every scale. Make scale-up decisions from data.
Connected foundations
Existing blueprints supplying governed records and execution
08 foundations
elnElectronic Laboratory Notebook (ELN) Software
Seal turns experiments into structured evidence. AI-configured methods evolve with your process. Unified with LIMS, MES, and QMS.
limsPharmaceutical QC LIMS Software
Seal checks results against live specs. AI-configured methods evolve with your process. Unified with MES, QMS, and ELN.
mesPharmaceutical MES & Manufacturing Execution Software
Seal captures the batch as it runs. AI-configured workflows evolve with your process. Unified with LIMS, QMS, and ELN.
PCPharmaceutical Process Characterization Software
Manage process characterization strategy, prior knowledge, risk assessments, DoE and edge-of-failure studies, parameter-to-quality relationships, scale and platform models, proven ranges, design-space claims, control-strategy decisions, and validation handoff.
TTPharmaceutical Technology Transfer Management Software
Seal transfers the process as data. AI-configured workflows evolve with your process. Unified with MES, QMS, and ELN.
UDBioprocess Upstream Development Software
Run cell-culture and fermentation development with governed cell lineage, media and feed versions, executable recipes, connected bioreactors, samples and assays, clone and process comparisons, scale-up models, perfusion state, harvest decisions, characterization, and technology transfer.
DDBioprocess Downstream Development Software
Run purification and formulation development with governed harvest inputs, buffers and solutions, chromatography and filtration methods, column and membrane lifecycle, fractions and pools, samples and assays, yield and clearance balances, holds, scale-up models, characterization, and technology transfer.
ADPharmaceutical Analytical Development Software
Analytical target profiles, experiments, method parameters, chromatographic and spectral evidence, forced degradation, robustness, control strategy, validation readiness, transfer, and lifecycle knowledge connected to ELN, SDMS, LIMS, instruments, and standards.
Pharmaceutical & Bioprocess Development Software owns the operating state above; connected foundations remain authoritative for their specialized records.

Capabilities

01native controlVersion-Controlled Processes
Processes as reusable assets, not disposable documents. Version history shows how the process evolved. Promote to GMP without re-authoring.
02native controlFlexible Development Workflows
Structured framework with configurable enforcement. Capture data consistently while scientists retain freedom to explore and iterate.
03native controlScale Modeling
Link bench-scale parameters to pilot and commercial predictions. See what worked at every scale. Make scale-up decisions from data.
04TTconnected foundationDigital Tech Transfer
Promote processes from development to GMP. Same data structure, tightened enforcement. No translation layer, no re-authoring.
05PCconnected foundationProcess Characterization
Design of experiments, parameter-quality relationships, design space definition. Characterization is built into development, not bolted on after.
06UDconnected foundationUpstream Development
Cell culture optimization, fermentation development, media studies. Connected to downstream and analytical as one integrated process.
07DDconnected foundationDownstream Development
Purification development, chromatography optimization, filtration studies. Same platform as upstream. Same data model. One process.
08ADconnected foundationAnalytical Method Development
Develop methods with flexibility. Lock them down for QC. Same platform, different enforcement. Handoff from development to testing without translation.

Entities

Entity
Description
Kind
FB
Process
Version-controlled, reusable. Not a document to archive. An asset to promote.
type
FB
GMP Process
The development process, promoted. Same data structure. Validated parameters. No re-authoring.
instance
FB
Tech Transfer Package
Not a PDF bundle. A promotable process definition with all context intact.
template
FB
Upstream Process
Cell bank or inoculum through culture and harvest with media, feeds, process signals, samples, holds, pools, and yields.
template
FB
Downstream Process
Clarification through purification and bulk with pools, columns, filters, buffers, viral safety, holds, samples, and yields.
template
B
Unit Operation
Upstream, downstream, analytical. Composable blocks that model your process as it actually exists.
type
D
Process Parameter
Captured during development. Becomes the CPP target range after characterization. Enforced in GMP.
type
LT
Experiment
Flexible execution during development. Same platform, different mode. Exploration when you need it.
type
TU
Scale Model
Bench → pilot → commercial. Predictions based on structured data, not tribal knowledge.
type
TU
Scale-Down Model
Qualified smaller-scale representation with target mechanisms, similarity criteria, limitations, and intended studies.
template
T
Product & Process Target
Intended product profile, quality attributes, process purpose, performance needs, constraints, risks, phase, and approval.
type
C
Development Material
Raw material, reagent, media, buffer, intermediate, standard, lot, attributes, preparation, storage, status, and use.
type
P
Development Run
Versioned process candidate executed with actual steps, materials, equipment, parameters, observations, interventions, samples, yields, and result.
type
P
PD-RUN-000184
Pilot purification run with actual materials, column lifecycle, parameter signals, pools, samples, yields, exceptions, and conclusion.
instance
S
Process Sample
Source run, unit operation, material state, time, location, chain of custody, tests, results, reserve, and disposition.
type
SC
Quality Attribute
Measured material or product property with target, method, result, criticality rationale, and process relationship.
type
L
Process Knowledge Claim
Evidence-backed relationship, mechanism, scale assumption, failure mode, operating region, uncertainty, and decision use.
type
F
Process Candidate
Versioned combination of unit operations, materials, parameters, controls, scale assumptions, evidence, risks, and maturity.
type
F
PROC-CAND-007
Selected late-stage process candidate with approved unit operations, set points, ranges, controls, gaps, and characterization plan.
instance
E
Process Maturity Decision
Evidence gate for selecting, scaling, characterizing, locking, transferring, validating, changing, or retiring a process candidate.
type

FAQ

ELNs are documentation systems. They capture what happened. Seal is an execution system. It defines what should happen, guides execution, and captures results. The difference matters at tech transfer: ELN outputs require translation to manufacturing systems, Seal processes promote directly.
Yes. Enforcement is configurable. During early development, scientists capture data in a structured framework but aren't constrained by it. As the process matures, controls tighten. The system adapts to the process lifecycle, not the other way around.
You promote the process from development to GMP. Same unit operations, same parameters, same equipment requirements. But with validated ranges, required approvals, and quality system integration. It's configuration, not re-authoring.
Legacy development data can be imported and linked to process definitions. The value compounds going forward. New development work is structured from the start, and legacy data provides historical context.
Same platform. When the process promotes to GMP, it executes on the same system with tightened controls. Deviations route to quality systems. Batch records generate automatically. Manufacturing runs the process development built.
Yes. The platform is 21 CFR Part 11 and Annex 11 compliant. For development work that needs GxP rigor. Late-stage clinical manufacturing, process characterization studies. The controls are there. For exploratory work, they're configurable.
Promotion supplies a governed starting definition and its evidence. Manufacturing still configures and approves the site-specific recipe, equipment mapping, instructions, controls, exceptions, and validation state. Seal removes re-entry and lost context without bypassing manufacturing or quality approval.
Typical criteria include a selected candidate, defined unit operations and parameters, representative materials and analytics, repeatability, scale-model rationale, sampling strategy, preliminary risk and control understanding, source-data completeness, and owned knowledge gaps.
They remain part of the process evidence. Factors, actual execution, results, exceptions, conclusions, and failure modes are searchable and can support risk assessments, operating boundaries, investigations, and avoidance of repeated dead ends.
Process development explores and selects the process candidate. Characterization systematically quantifies parameter and material effects on process performance and quality attributes to support a control strategy. Seal connects them through the same candidate, runs, parameters, samples, and claims.

Related blueprints

cmcCMC Data & Module 3 Content Management Software

Every CMC claim tied to its source, approved state, and submission history.

Connect product definitions, processes, specifications, methods, characterization, validation, stability, claims, CTD sections, market variants, review, and post-approval change without rebuilding truth in documents.

biotechBiotech Startup Operations & Quality Software

Skip the GMP wall.

R&D flexibility. GMP compliance. No migration.

APRGxP Automated Reporting & Quality Intelligence Software

A signed conclusion with every number, rule, and source still attached.

Controlled report definitions, governed metrics, frozen data cuts, traceable tables and narratives, review, approval, scheduling, distribution, and live quality intelligence across GxP operations.

msatMSAT Process Knowledge & Manufacturing Support Software

Development intent to manufacturing reality. Every signal, investigation, change, and transfer strengthens the process model.

Run Manufacturing Science and Technology across process ownership, technology transfer, site and product knowledge, batch monitoring, process signals, investigations, change impact, validation and CPV, improvement, comparability, commitments, and governed manufacturing support.

inventoryPharmaceutical Inventory & Material Lot Management Software

Every material lot, container, quantity, state, place, movement, and use reconciled.

Material definitions, supplier and internal lots, containers, aliquots, labels, status, locations, quantities, expiry and retest, reservations, movements, usage, adjustments, storage excursions, reconciliation, traceability, and disposition.

cdmoCDMO Manufacturing & Quality Management Software

You sell capacity. You deliver trust.

Per-client data isolation without vendor consultants. AI-configured Blueprints per client. Unified with MES, LIMS, and QMS.

Go live in 48 hours.